Minder, A.-E.; Schneider-Yin, X.; Zulewski, H.; Minder, C.E.; Minder, E.I.
Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria. Life 2023, 13, 1066.
https://doi.org/10.3390/life13041066
AMA Style
Minder A-E, Schneider-Yin X, Zulewski H, Minder CE, Minder EI.
Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria. Life. 2023; 13(4):1066.
https://doi.org/10.3390/life13041066
Chicago/Turabian Style
Minder, Anna-Elisabeth, Xiaoye Schneider-Yin, Henryk Zulewski, Christoph E. Minder, and Elisabeth I. Minder.
2023. "Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria" Life 13, no. 4: 1066.
https://doi.org/10.3390/life13041066
APA Style
Minder, A.-E., Schneider-Yin, X., Zulewski, H., Minder, C. E., & Minder, E. I.
(2023). Afamelanotide Is Associated with Dose-Dependent Protective Effect from Liver Damage Related to Erythropoietic Protoporphyria. Life, 13(4), 1066.
https://doi.org/10.3390/life13041066